drugset / Trial / NCT00196846
Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
RandomizedParallel-groupOpen-labelPrevention
Summary
Study done in young breast cancer patients to prevent chemotherapy induced ovarian failure
Timeline
- Start
- 2005-03
- Primary completion
- 2008-12
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Goserelin | Other / unclassified | 3.6 mg | Subcutaneous |